OBJECTIVES: To evaluate the clinical effectiveness of Kanakasava and Swasanandam Gulika in Bronchial Asthma.   METHODS: A randomized single blind clinical study with pretest and posttest design in 2 groups’s standard and trail were adopted, where the patients were given treatment with specific duration with follow up. In total 342 patients were selected from the OPD and IPD of Muniyal Institute of Ayurveda Medical Sciences Manipal enrolled for the present study out of which 22 were dropped out from the study. Routine hematological, bio-chemical and urine analysis were recorded. The main Signs and Symptoms Breathlessness, Wheezing, cough, Sneezing, Dysponea, head ache, were taken for assessment as symptoms grade parameters. Peak expiatory flow rate (PEFR), Absolute Eosinophil count (AEC), and ESR  also taken for the assessment as Laboratory parameters. Data obtained from the above mentioned study was statistically analyzed by using the Z test.  RESULTS: Kanakasava and Swasanandam Gulika provided 67.5%. relief in Wheezing, 75.86% relief in Dysponea , 66.07%, relief in cough, 54.78% relief in Sneezing and 43.22% relief in Head ache which were statistically highly significant result p<0.001, where as in PEFR, AEC and ESR provided 92.85%, 23% and 35.89% relief respectively which were also statistically highly significant result p<0.001.   CONCLUSIONS: Kanakasava and Swasanandam Gulika appear to be beneficial in Bronchial Asthma along with its symptoms. Bronchial Asthma is considered as chronic airway inflammatory disease. The effects in every condition and in complications are still being evaluated.